PL414044A1 - Plaster containing bactericidal and/or bacteriostatic and/or viricidal and/or fungicidal substances used topically as an innovative form of application in treatment of body injuries - Google Patents
Plaster containing bactericidal and/or bacteriostatic and/or viricidal and/or fungicidal substances used topically as an innovative form of application in treatment of body injuriesInfo
- Publication number
- PL414044A1 PL414044A1 PL414044A PL41404415A PL414044A1 PL 414044 A1 PL414044 A1 PL 414044A1 PL 414044 A PL414044 A PL 414044A PL 41404415 A PL41404415 A PL 41404415A PL 414044 A1 PL414044 A1 PL 414044A1
- Authority
- PL
- Poland
- Prior art keywords
- application
- bacteriostatic
- viricidal
- treatment
- substances used
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Abstract
Przedmiotem zgłoszenia jest innowacyjna forma aplikacji substancji bakteriobójczych i/lub bakteriostatycznych i/lub wirusobójczych i/lub grzybobójczych, w postaci plastrów zawierających jedną lub kilka substancji czynnych. Struktura plastra opiera się na możliwości magazynowania i kontrolowanego uwalniania substancji biologicznie czynnych. Substancje aktywne, w zależności od konstrukcji plastra, mogą podlegać modyfikowanemu uwalnianiu (np. przedłużonemu). Właściwości lecznicze produktu są składowymi wszystkich składników danego produktu. Analizy wykazały również synergię działania w przypadku kilku produktów.The subject of the application is an innovative form of application of bactericidal and / or bacteriostatic and / or virucidal and / or fungicidal substances, in the form of patches containing one or several active substances. The structure of the patch is based on the possibility of storage and controlled release of biologically active substances. Active substances, depending on the patch structure, may be subject to modified release (e.g. prolonged). The medicinal properties of the product are components of all ingredients of the product. Analyzes also showed synergy of action for several products.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL414044A PL414044A1 (en) | 2015-09-17 | 2015-09-17 | Plaster containing bactericidal and/or bacteriostatic and/or viricidal and/or fungicidal substances used topically as an innovative form of application in treatment of body injuries |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL414044A PL414044A1 (en) | 2015-09-17 | 2015-09-17 | Plaster containing bactericidal and/or bacteriostatic and/or viricidal and/or fungicidal substances used topically as an innovative form of application in treatment of body injuries |
Publications (1)
Publication Number | Publication Date |
---|---|
PL414044A1 true PL414044A1 (en) | 2017-03-27 |
Family
ID=58360269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL414044A PL414044A1 (en) | 2015-09-17 | 2015-09-17 | Plaster containing bactericidal and/or bacteriostatic and/or viricidal and/or fungicidal substances used topically as an innovative form of application in treatment of body injuries |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL414044A1 (en) |
-
2015
- 2015-09-17 PL PL414044A patent/PL414044A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2019004137A2 (en) | 1,2,4-triazolones 2,4,5-trisubstituted | |
UY37460A (en) | 1,2,4-TRIAZOLONS WITH ANALATION IN 4 AND 5 | |
EP4218823A3 (en) | Novel polymeric hgh prodrugs | |
EP4272832A3 (en) | Antimicrobial compounds, compositions, and uses thereof | |
WO2016116403A8 (en) | Polyurethaneurea solutions for compositions with active ingredients or fragrances | |
TN2015000406A1 (en) | Antimicrobial compositions and related methods of use | |
PH12020550232A1 (en) | Pesticide composition containing thidiazuron and polyglutamic acid | |
MX2018008645A (en) | 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives. | |
PH12019501424A1 (en) | Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor | |
WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
MX2016016400A (en) | Stabilized oxymetazoline formulations and their uses. | |
IL251555B (en) | Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases | |
ZA201905309B (en) | Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals | |
UY37867A (en) | FORMULATION OF TOPIC USE FOR CONTROL AND PREVENTION OF PARASITES IN ANIMALS | |
MX2019011951A (en) | Bacterial secretome for use in the treatment of skin lesions. | |
PL414044A1 (en) | Plaster containing bactericidal and/or bacteriostatic and/or viricidal and/or fungicidal substances used topically as an innovative form of application in treatment of body injuries | |
CO2020007892A2 (en) | Use of functionalized calcium carbonate as active ingredient | |
PL414045A1 (en) | Plaster containing antifungal substances in the form of a plaster, acting topically in treatment of skin mycosis | |
WO2014137231A3 (en) | Totarol extract formulations and uses thereof | |
PL408262A1 (en) | Plaster containing an anti-swelling substances as an innovative form of application in treatment of bruises and injuries of motor organs | |
PL408261A1 (en) | Plaster containing an analgesic substances as an innovative form of application, soothing and treating pain | |
BR112017020100A2 (en) | herbicidal compositions comprising isoxaflutol and diflufenican | |
CL2012002768A1 (en) | Antiseptic solution for prevention of subclinical mastitis in dairy cows comprising a mixture of propolis and solution of honey bees in proportions from 1: 5 to 5: 1, use of the antiseptic solution because it serves for the prophylaxis, prevention and control of subclinical mastitis of dairy cows. | |
UA106472U (en) | Composition for treating dermatological diseases | |
TH180790A (en) | Compositions containing substances for the regulation of the expression of ABH antigens. |